ProPhase Labs, Inc.
PRPH
$0.416
$0.00852.09%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -62.39% | -81.28% | -81.17% | -83.97% | -65.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -62.39% | -81.28% | -81.17% | -83.97% | -65.43% |
| Cost of Revenue | -45.16% | -56.42% | -53.69% | -37.81% | -50.62% |
| Gross Profit | -107.09% | -107.38% | -104.12% | -127.08% | -80.56% |
| SG&A Expenses | -7.22% | -27.42% | -8.50% | -37.04% | 9.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.33% | -42.37% | -35.25% | -44.82% | -33.28% |
| Operating Income | -22.52% | -68.03% | -1,048.34% | -123.03% | -431.69% |
| Income Before Tax | -34.05% | -71.75% | -1,665.78% | -124.80% | -481.82% |
| Income Tax Expenses | -52.55% | -55.16% | -18,428.57% | -6.16% | -303.21% |
| Earnings from Continuing Operations | -28.13% | -78.87% | -1,239.09% | -258.06% | -631.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.13% | -78.87% | -1,239.09% | -258.06% | -631.10% |
| EBIT | -22.52% | -68.03% | -1,048.34% | -123.03% | -431.69% |
| EBITDA | -18.48% | -87.56% | -405.12% | -128.39% | -245.00% |
| EPS Basic | -15.34% | -59.55% | -1,158.54% | -222.06% | -591.46% |
| Normalized Basic EPS | -20.66% | -53.21% | -1,556.67% | -117.47% | -453.22% |
| EPS Diluted | -16.67% | -61.61% | -1,167.07% | -227.62% | -619.93% |
| Normalized Diluted EPS | -20.66% | -53.21% | -1,668.72% | -117.47% | -549.73% |
| Average Basic Shares Outstanding | 11.09% | 12.13% | 7.74% | 11.15% | 8.03% |
| Average Diluted Shares Outstanding | 11.09% | 12.13% | -0.09% | 11.15% | -15.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
